Max Healthcare Institute Ltd

Max Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Max Healthcare Institute Ltd

₹ 908 -0.63%
13 Sep - close price
maxhealthcare.in BSE: 543220 NSE: MAXHEALTH
About

Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals providing operation and management, medical services, clinical, radiology, pathology services and related healthcare services. [1]

Key Points

Leadership[1]
Max Healthcare is India’s second largest hospital chain in terms of revenue, EBITDA and market capitalisation.

Website BSE NSE
  • Market Cap ₹ 88,251 Cr.
  • Current Price ₹ 908
  • High / Low ₹ 980 / 531
  • Stock P/E 123
  • Book Value ₹ 79.0
  • Dividend Yield 0.17 %
  • ROCE 11.7 %
  • ROE 9.34 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 100% CAGR over last 5 years

Cons

  • Stock is trading at 11.5 times its book value
  • Company has a low return on equity of 8.49% over last 3 years.
  • Earnings include an other income of Rs.271 Cr.
  • Promoter holding has decreased over last 3 years: -46.7%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
500 462 398 393 440 474 482 507 544 597 591 610 621
376 353 294 298 317 322 328 354 384 394 391 411 423
Operating Profit 124 109 104 96 123 152 154 154 160 203 200 199 198
OPM % 25% 24% 26% 24% 28% 32% 32% 30% 29% 34% 34% 33% 32%
27 30 42 27 29 32 44 41 43 48 43 138 43
Interest 11 15 11 13 13 13 13 14 14 13 10 15 8
Depreciation 25 28 25 28 28 28 28 30 28 28 30 32 30
Profit before tax 115 96 110 82 111 144 157 151 161 210 203 291 203
Tax % 24% 23% 5% 19% 22% -149% 22% 16% 22% 23% 22% 17% 24%
88 75 104 67 87 359 122 126 126 161 158 242 154
EPS in Rs 0.91 0.77 1.07 0.69 0.90 3.70 1.26 1.30 1.30 1.66 1.63 2.49 1.59
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
591 790 912 984 1,059 1,008 59 1,031 1,775 1,905 2,341 2,419
615 768 890 941 1,048 976 65 870 1,332 1,321 1,579 1,619
Operating Profit -24 22 22 43 11 31 -6 161 443 584 762 800
OPM % -4% 3% 2% 4% 1% 3% -10% 16% 25% 31% 33% 33%
39 33 35 30 51 47 66 -104 128 144 271 271
Interest 42 43 30 35 41 44 60 112 59 52 52 46
Depreciation 31 49 50 51 49 53 3 91 112 113 117 119
Profit before tax -58 -38 -24 -13 -28 -18 -3 -146 400 563 865 907
Tax % 0% 0% -0% 0% 0% 26% -5% 12% 17% -23% 21%
-58 -38 -24 -13 -28 -23 -3 -164 332 694 687 715
EPS in Rs -1.46 -0.78 -0.44 -0.24 -0.51 -0.43 -0.06 -1.70 3.42 7.15 7.07 7.37
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 14% 21%
Compounded Sales Growth
10 Years: %
5 Years: 18%
3 Years: 31%
TTM: 21%
Compounded Profit Growth
10 Years: %
5 Years: 100%
3 Years: 121%
TTM: -2%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 32%
1 Year: 59%
Return on Equity
10 Years: %
5 Years: 7%
3 Years: 8%
Last Year: 9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 395 489 533 537 537 537 537 966 970 971 972
Reserves 167 523 762 770 773 749 2,338 4,973 5,342 6,071 6,709
505 296 273 314 386 390 658 480 556 534 443
223 141 171 210 278 274 20 724 945 845 945
Total Liabilities 1,290 1,449 1,740 1,832 1,973 1,951 3,553 7,143 7,812 8,420 9,069
468 430 424 429 502 479 90 2,989 4,493 4,485 4,717
CWIP 10 15 6 30 7 10 0 8 60 103 235
Investments 238 451 840 866 799 770 2,471 2,379 1,447 1,475 1,915
574 554 469 508 665 693 992 1,766 1,811 2,358 2,202
Total Assets 1,290 1,449 1,740 1,832 1,973 1,951 3,553 7,143 7,812 8,420 9,069

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
39 64 33 52 -19 128 224 447 696 613
-200 -330 -66 -89 55 -193 -105 -670 302 -806
176 251 34 36 -36 329 412 -161 -54 -246
Net Cash Flow 15 -16 0 -0 -0 265 532 -384 944 -438

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 97 67 48 55 68 103 517 109 56 27 32
Inventory Days 18 20 18 19 22 25 33 20 31 24
Days Payable 158 171 183 206 250 335 297 159 230 225
Cash Conversion Cycle -42 -85 -117 -132 -161 -206 517 -155 -83 -172 -169
Working Capital Days 27 3 2 4 -4 32 3,558 35 12 -39 -26
ROCE % 0% 1% 1% 2% 2% 4% 7% 9% 12%

Shareholding Pattern

Numbers in percentages

1 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
60.91% 60.68% 50.64% 50.64% 23.80% 23.78% 23.77% 23.76% 23.76% 23.75% 23.75% 23.74%
14.23% 16.67% 14.59% 23.34% 49.27% 50.15% 51.96% 59.89% 60.39% 60.69% 57.33% 56.99%
8.70% 15.67% 17.57% 19.42% 21.16% 20.47% 19.36% 11.90% 11.40% 11.55% 14.96% 15.36%
16.16% 6.97% 17.20% 6.61% 5.76% 5.61% 4.92% 4.45% 4.45% 3.99% 3.97% 3.91%
No. of Shareholders 91,9371,11,8771,20,0791,05,0001,01,6591,11,7011,04,6561,11,3741,18,6351,11,3381,27,0091,36,254

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls